but if she scales up, she is just becoming a corporate. So what advantage does she have?
Medicare rebates for ivf are yet to fall and I can’t see that happening despite posturing. People will pay for perceived quality and companies like Mvf who have established records and locations with big marketing budgets will do reasonably imo. Lynn has a great name in the space which will help her but patients will want her not some other random dr.
Ann: Appendix 4D and Interim Financial Report 31 December 2018, page-20
Add MVF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.008(0.67%) |
Mkt cap ! $465.6M | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.15 | $1.11 | $562.4K | 503.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 27229 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 1739 | 1 |
View Market Depth
| Last trade - 11.00am 19/11/2024 (20 minute delay) ? |
| MVF (ASX) Chart |
